Enavate Sciences GP
Latest statistics and disclosures from Enavate Sciences GP's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ZBIO, SION, IMNM, UPB, Bridgebio Oncology Therapeut, and represent 88.21% of Enavate Sciences GP's stock portfolio.
- Added to shares of these 1 stock: Bridgebio Oncology Therapeut (+$30M).
- Started 1 new stock position in Bridgebio Oncology Therapeut.
- Enavate Sciences GP was a net buyer of stock by $30M.
- Enavate Sciences GP has $328M in assets under management (AUM), dropping by 85.53%.
- Central Index Key (CIK): 0001953107
Tip: Access up to 7 years of quarterly data
Positions held by Enavate Sciences GP consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Enavate Sciences GP
Enavate Sciences GP holds 7 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Zenas Biopharma (ZBIO) | 25.5 | $84M | 3.8M | 22.20 |
|
|
| Sionna Therapeutics (SION) | 22.3 | $73M | 2.5M | 29.41 |
|
|
| Immunome (IMNM) | 17.0 | $56M | 4.8M | 11.71 |
|
|
| Upstream Bio (UPB) | 14.1 | $46M | 2.5M | 18.81 |
|
|
| Bridgebio Oncology Therapeut Com New | 9.3 | $30M | NEW | 2.6M | 11.58 |
|
| Compass Therapeutics (CMPX) | 8.3 | $27M | 7.8M | 3.50 |
|
|
| Camp4 Therapeutics Corp (CAMP) | 3.5 | $11M | 3.8M | 3.00 |
|
Past Filings by Enavate Sciences GP
SEC 13F filings are viewable for Enavate Sciences GP going back to 2025
- Enavate Sciences GP 2025 Q3 filed Nov. 14, 2025
- Enavate Sciences GP 2025 Q2 filed Aug. 14, 2025
- Enavate Sciences GP 2025 Q1 filed May 15, 2025